Hasan Ebrahimi Shahmabadi

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 9

Top Topics

Methicillin Resistant Staphylococcus Aureus

Silver Nanoparticles

Top Venues

International journal of molecular sciences

Journal of drug targeting

Journal of clinical medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Seyed Ebrahim Alavi, Max Gholami, Hasan Ebrahimi Shahmabadi, Peter Reher
Resorbable GBR Scaffolds in Oral and Maxillofacial Tissue Engineering: Design, Fabrication, and Applications. Journal of clinical medicine 12 (22) (2023)
Seyed Ebrahim Alavi, Aun Raza, Max Gholami, Michael Giles, Rayan Al-Sammak, Ali Ibrahim, Hasan Ebrahimi Shahmabadi, Lavanya A Sharma
Advanced Drug Delivery Platforms for the Treatment of Oral Pathogens. Pharmaceutics 14 (11) (2022)
Mohsen Ghaferi, Aun Raza, Maedeh Koohi, Warda Zahra, Azim Akbarzadeh, Hasan Ebrahimi Shahmabadi, Seyed Ebrahim Alavi
Impact of PEGylated Liposomal Doxorubicin and Carboplatin Combination on Glioblastoma. Pharmaceutics 14 (10) (2022)
Seyed Ebrahim Alavi, Urooj Bakht, Maedeh Koohi Moftakhari Esfahani, Hossein Adelnia, Seyed Hossein Abdollahi, Hasan Ebrahimi Shahmabadi, Aun Raza
A PEGylated Nanostructured Lipid Carrier for Enhanced Oral Delivery of Antibiotics. Pharmaceutics 14 (8) (2022)
Gholamhossein Hassanshahi, Seyed Ebrahim Alavi, Hossein Khorramdelazad, Zahra Ahmadi, Ali Fattahi Bafghi, Seyed Hossein Abdollahi, Hasan Ebrahimi Shahmabadi
Serum levels of CC chemokine ligands in cutaneous leishmaniasis patients. Journal of parasitic diseases : official organ of the Indian Society for Parasitology 45 (1) (2020)
Sara Yousefi Aldashi, Zahra Saffari, Hasan Ebrahimi Shahmabadi, Azim Akbarzadeh
In Vitro Assessment of Magnetic Liposomal Paclitaxel Nanoparticles as a Potential Carrier for the Treatment of Ovarian Cancer. Advanced pharmaceutical bulletin 11 (2) (2020)
Mohsen Ghaferi, Mohammad Javad Asadollahzadeh, Azim Akbarzadeh, Hasan Ebrahimi Shahmabadi, Seyed Ebrahim Alavi
Enhanced Efficacy of PEGylated Liposomal Cisplatin: In Vitro and In Vivo Evaluation. International journal of molecular sciences 21 (2) (2020)
Mohsen Ghaferi, Maedeh Koohi Moftakhari Esfahani, Aun Raza, Sitah Alharthi, Hasan Ebrahimi Shahmabadi, Seyed Ebrahim Alavi
Mesoporous silica nanoparticles: synthesis methods and their therapeutic use-recent advances. Journal of drug targeting 29 (2) (2020)
Seyed Ebrahim Alavi, Sitah Muflih Al Harthi, Hasan Ebrahimi Shahmabadi, Azim Akbarzadeh
Cisplatin-Loaded Polybutylcyanoacrylate Nanoparticles with Improved Properties as an Anticancer Agent. International journal of molecular sciences 20 (7) (2019)